Sayre focuses on co-development of novel assets with potential licensors. Sayre co-invests in clinical studies for US, EU and Japan approved drugs once they are mandated by the Indian health authorities. Sayre designs clinical studies keeping in mind the unique Indian ethnic profile and thereby help therapy customization. These studies are designed also to include other important parameters such as Health-economics and Quality of Life (QoL) which help in demonstrating the drug benefits in terms of reduced hospital stay, lower costs and improved QoL.
The Sayre team members come with a demonstrated track record of successful novel product registrations in the Indian sub-continent. Sayre will work with health authorities in India and other South Asian countries to simplify and build an easy to travel regulatory pathway for our Licensors. Sayre team will design and conduct appropriate local clinical trials or post-marketing studies to facilitate and secure registrations for novel drugs, drug-delivery devices and companion diagnostics.
Sayre’s medical and product management team coupled with high-science Key Account Managers (KAMs) engage Oncologists and Rheumatologists to position its high-value solutions for life threatening diseases afflicting the South Asian patient population. The sales and marketing leadership teams bring in their experience and expertise in brand building through scientific brand promotion and initiatives. The senior corporate leadership team has a successful track record in commercializing proprietary as well as niche brands in India and SAARC region.
Sayre has robust warehousing & distribution services through its partnership with one of India’s leading pharmaceutical distribution and logistics service provider – India’s first WHO GDP certified in the super specialty segment. The well-established network of distribution centers provide the essential presence of Sayre’s brands and services across the length and breadth of the country.
Sayre has partnered with reputed companies in SAARC to commercialise its assets with a strong know-how of drug regulations required in SAARC markets. Sayre has identified and fostered valuable relationships with regional partners who have a strong know-how of the local healthcare community with the commercial and medical teams of Sayre overseeing the SAARC operations.